Proceedings of the 9th International Multidisciplinary Conference «Stress and Behavior» Saint-Petersburg, Russia, 16–19 May 2005.The problem of preclinical diagnostics of Alzheimer’s Disease (AD) is getting the growing importance due to a dramatic growth of anti-AD therapy. Neurogenerative dementia may remain unrecognized for a long time (months or years) since its initial symptoms are usually regarded as normal ageing. Therefore, identification of symptoms of progressing cognitive deficiency and their differentiation from mild cognitive impairment (MCI) of nonprogressive character is very important.Methods. The study group consisted of elderly persons from the relatives of AD patients observed in the Department of Alzheimer’s Disease, or o...
The consequences for cognitive functioning of normal aging, depression and dementia are well known. ...
Abstract Executive deficits as well as deficits in episodic memory characterize the initial phases o...
Mild cognitive impairment (MCI) is an intermediate clinical state between normal aging and dementia,...
Proceedings of the 9th International Multidisciplinary Conference «Stress and Behavior» Saint-Peters...
Neuropsychological aspects of preclinical stages of neurodegenerative diseases are an extensively st...
With an aging population and an increasing number of individuals with Alzheimer’s disease (AD), a co...
Proceedings of the 9th International Multidisciplinary Conference «Stress and Behavior» Saint-Peters...
International audienceIntroduction The number of older people diagnosed with amnestic mild cognitive...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting a range of cognitive ...
Abstract Mild cognitive impairment (MCI) was defined by Petersen et al. (1999) as progressive memory...
To test the validity of the new diagnostic criteria for Alzheimer’s disease (AD) in a naturalistic s...
The field of aging and dementia research is advancing rapidly toward the stage of earlier identifica...
Test scores from a comprehensive neuropsychological battery administered to 1602 subjects consisting...
variety of clinically-defined predementia syndromes, with differing diagnostic criteria and nomencla...
A variety of clinically-defined predementia syndromes, with differing diagnostic criteria and nomenc...
The consequences for cognitive functioning of normal aging, depression and dementia are well known. ...
Abstract Executive deficits as well as deficits in episodic memory characterize the initial phases o...
Mild cognitive impairment (MCI) is an intermediate clinical state between normal aging and dementia,...
Proceedings of the 9th International Multidisciplinary Conference «Stress and Behavior» Saint-Peters...
Neuropsychological aspects of preclinical stages of neurodegenerative diseases are an extensively st...
With an aging population and an increasing number of individuals with Alzheimer’s disease (AD), a co...
Proceedings of the 9th International Multidisciplinary Conference «Stress and Behavior» Saint-Peters...
International audienceIntroduction The number of older people diagnosed with amnestic mild cognitive...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting a range of cognitive ...
Abstract Mild cognitive impairment (MCI) was defined by Petersen et al. (1999) as progressive memory...
To test the validity of the new diagnostic criteria for Alzheimer’s disease (AD) in a naturalistic s...
The field of aging and dementia research is advancing rapidly toward the stage of earlier identifica...
Test scores from a comprehensive neuropsychological battery administered to 1602 subjects consisting...
variety of clinically-defined predementia syndromes, with differing diagnostic criteria and nomencla...
A variety of clinically-defined predementia syndromes, with differing diagnostic criteria and nomenc...
The consequences for cognitive functioning of normal aging, depression and dementia are well known. ...
Abstract Executive deficits as well as deficits in episodic memory characterize the initial phases o...
Mild cognitive impairment (MCI) is an intermediate clinical state between normal aging and dementia,...